Enbrel (etanercept), Wyeth's biological treatment for rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and psoriasis, is now available as a new easy-to-use pre-filled auto-injector device, known as the Enbrel MYCLIC pen. The Enbrel MYCLIC pen is a single-use auto-injector, designed to deliver Enbrel as a 50mg subcutaneous injection...

PSA is supporting the release of a new Eczema management resource - Eczema Management Guide For The Pharmacist during National Eczema Awareness Week which runs until 13 September. Eczema is a skin condition which affects about one in three Australians at some time in their lives. It usually starts when a child is a baby and is sometimes gone by the time the child is about six...

PSA is supporting the release of a new Eczema management resource - Eczema Management Guide For The Pharmacist during National Eczema Awareness Week which runs until 13 September. Eczema is a skin condition which affects about one in three Australians at some time in their lives. It usually starts when a child is a baby and is sometimes gone by the time the child is about six...

Can-Fite BioPharma (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today that its 75-patient Phase II clinical study with CF101 to treat patients with moderate to severe Psoriasis has successfully met its primary objectives...

Can-Fite BioPharma (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today that its 75-patient Phase II clinical study with CF101 to treat patients with moderate to severe Psoriasis has successfully met its primary objectives...